Imprimis NJOF, LLC is recalling approximately 15,414 units of Epinephrine-Lidocaine HCl (0.25 mg/mL and 7.5 mg/mL) Preservative-Free, 1 mL single-use vials. The recall was initiated because the product was found to be out of specification for assay, meaning the potency of the medication may not meet required standards. If you have concerns about medical treatments involving this drug, please contact your healthcare provider or pharmacist.
Incorrect potency of epinephrine or lidocaine could lead to ineffective local anesthesia or an inadequate vasoconstrictor response during medical procedures. No incidents or injuries have been reported to date.
Quantity affected: 15,414 units
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.